GLP-1-class medicines and investigational compounds. Semaglutide and tirzepatide are registered in the Philippines as prescription medicines; retatrutide is in phase 3 trials and approved nowhere.
- Weight loss
Semaglutide
GLP-1 analogueGLP-1 agonist, the active ingredient in Ozempic and WegovyApproved medicine - Weight loss
Tirzepatide
Peptide dual incretin receptor agonistGIP and GLP-1 dual agonist, the active ingredient in MounjaroApproved medicine - Weight loss
Cagrilintide
Long-acting amylin analogue in clinical trialsPhase 3 human - Weight loss
Mazdutide
GLP-1 and glucagon dual agonist in clinical trialsPhase 3 human - Weight loss
Retatrutide
Peptide triple hormone receptor agonistGLP-1, GIP and glucagon triple agonist in phase 3 trialsPhase 3 human - Weight loss
5-Amino-1MQ
NNMT inhibitor studied in animal models of metabolismResearch - Weight loss
AOD-9604
Growth hormone fragment studied for fat metabolismResearch
